Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Five of EU-27 account for 68% of pharma trade, report finds

March 27, 2025 Market Research Logista Freight, Pharmacy, european union, market report, trade

Logista Freight has found that Germany, France, Belgium, Italy and the Netherlands account for up to 68% of trade in …
News

Cardinal Health’s Kangaroo OMNI™ Enteral Feeding Pump to launch in new international markets in 2025

February 6, 2025 Sales and Marketing Kangaroo, enteral, feeding pump

The next generation Kangaroo OMNI™ enteral feeding pump delivers nutrition and hydration from hospital to home. DUBLIN, Ireland, Feb.4, 2025 …
News
Press release

CANDOR Bioscience acquired by Medix Biochemica

January 31, 2025 Sales and Marketing CANDOR biosciences, Diagnostics, Medix biochemica, acquisition, in vitro diagnostics

CANDOR Biosciences, a supplier in immunoassay solutions, has been acquired by Medix Biochemica, a supplier of raw materials for in …
News

NICE issues positive final guidance for treatment of Duchenne Muscular Dystrophy from Santhera

January 29, 2025 Sales and Marketing Duchenne Muscular Dystrophy, EC, EMA, FDA, Santhera Pharmaceuticals, positive

Santhera Pharmaceuticals has received positive final guidance from the National Institute for Care and Excellence (NICE) for AGAMREE (vamorolone) to …
News

First patients treated with HEMGENIX® (etranacogene dezaparvovec) gene therapy for haemophilia B in Denmark

January 21, 2025 Sales and Marketing CSL, Denmark, genetic, haemophilia, treatment

21 January 2025 – Copenhagen, Denmark – CSL Behring Denmark today announced that the first Danish patients with haemophilia B …
News
Press release

Pharma services boom in China as CPHI & PMEC China posts record attendance

August 8, 2024 Conferencing, Events & Incentives, Public Relations, Sales and Marketing CPHI China, PMEC China, pharma

Domestic and international markets in Asia surging as CPHI & PMEC China welcomes a staggering 93,000 attendees 08 August, 2024, …
News
Press release

GSK and CureVac to restructure collaboration into licensing agreement

July 3, 2024 Sales and Marketing CureVac, GSK, Immunology, License Agreement, collaboration

GSK and CureVac have announced that they have restructured their existing collaboration into a license agreement, which is intended to …
News

Alvotech and Advanz Pharma announce commercialisation agreement for Eylea biosimilar

June 18, 2024 Sales and Marketing Advanz Pharma, Alvotech, Opthalmology, biosimilar

Alvotech and Advanz Pharma have announced an exclusive partnership agreement surrounding the supply and commercialisation of AVT06, Alvotech’s proposed biosimilar …
News
genes

Shionogi and Maze Therapeutics announce worldwide exclusive licensing agreement for novel Pompe disease candidate

May 10, 2024 Sales and Marketing Pompe disease, Rare Diseases, Shionogi, licensing agreement, maze therapeutics

Japanese pharmaceutical company Shionogi and US-based Maze Therapeutics have finalised an exclusive worldwide license agreement for MZE001, a novel therapeutic …
News
Vaccine image

Sanofi and Novavex sign exclusive $1.2bn licensing agreement to co-commercialise COVID-19 vaccine and develop flu-COVID-19 vaccines

May 10, 2024 Sales and Marketing COVID-19, COVID-19 vaccine, Immunology, Novatex, Sanofi, flu-COVID-19 vaccine, licensing agreement

French pharma and healthcare company Sanofi and US biotech Novavex, have entered into a co-exclusive licensing agreement for a number …
News
az_vaccine

AstraZeneca withdraws COVID-19 vaccine Vaxzevria

May 9, 2024 Sales and Marketing AstraZeneca, COVID-19, Immunology, thrombosis with thrombocytopenia syndrome

UK-based pharmaceutical company AstraZeneca has announced that is it voluntarily withdrawing its COVID-19 vaccine Vaxzevria due to a drop in …
News

Ironic Biotech announces $1m funding to develop iron deficiency and anaemia treatment

April 4, 2024 Sales and Marketing Haematology, Ironic Biotech, anaemia, funding, iron deficiency

Swedish biotech startup Ironic Biotech has announced that it has successfully closed a pre-seed funding round of $1m, led by …
News

Venatorx and Menarini enter commercial agreement for cefepime-taniborbactam

January 11, 2024 Sales and Marketing Infections and infestations, Menarini Group, Venatorx Pharmaceuticals, cefepime-taniborbactam, collaboration

Venatorx Pharmaceuticals and Menarini Group have announced that they have entered into a commercial agreement valid in 96 countries in …
News

Consilient Health to launch Cytisine smoking cessation treatment in UK

January 8, 2024 Sales and Marketing Cytisine, Smoking Cessation, consilient health, smoking cessation

Consilient Health has announced that it plans to launch Cytisine 1.5mg tablets in the UK on 22 January 2024. The …
News

C4X receives $11m milestone payment from AstraZeneca

January 3, 2024 Sales and Marketing AstraZeneca, C4X, C4X Discovery, Chronic Diseases

C4X Discovery Holdings has announced that it has received a milestone payment of $11m from AstraZeneca which has been triggered …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026